![Robert Georgantas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Georgantas
No open positions remaining
Profile
Robert W.
Georgantas worked at Biodesix, Inc. from 2019 to 2023 as Senior VP-Research & Translational Science.
From 2023 to 2024, worked at Providence Therapeutics, Inc. as President & Chief Technology Officer.
Dr. Georgantas earned a doctorate from The Johns Hopkins University School of Medicine.
Former positions of Robert Georgantas
| Companies | Position | End |
|---|---|---|
Providence Therapeutics, Inc.
 Providence Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative immunotherapeutic for cancer treatment | President | 01/03/2024 |
| BIODESIX, INC. | Corporate Officer/Principal | 01/02/2023 |
Training of Robert Georgantas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence Therapeutics, Inc.
Providence Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative immunotherapeutic for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Robert Georgantas
